Chronic Kidney Disease and the Adiposity Paradox: Valid or Confounded?

Area of Science:

• Nephrology
• Gerontology
• Public Health

Background:

• Obesity, often measured by Body Mass Index (BMI), is paradoxically associated with reduced mortality risk in individuals with Chronic Kidney Disease (CKD).
• Traditional obesity metrics like BMI and percent body fat (%BF) can be influenced by muscle mass, necessitating more precise measures.
• Fat Mass Index (FMI), derived from Dual-energy X-ray absorptiometry (DXA), offers a more accurate assessment of adiposity, independent of muscle mass.

Purpose of the Study:

• To compare the relationship between various obesity indicators (BMI, %BF, FMI) and mortality risk in CKD patients.
• To investigate whether muscle mass, inflammation, or prior weight loss modify the observed association between obesity and mortality in CKD.

Main Methods:

• Utilized data from 2,852 NHANES participants with CKD (1999-2006) linked to the National Death Index through 2011.
• Defined obesity using BMI, %BF, and DXA-derived FMI cut-offs.
• Employed Cox proportional hazards models to analyze the association between adiposity measures and mortality.

Main Results:

• Obesity, assessed by FMI (continuous and categorical), BMI, and %BF, was associated with lower mortality risk.
• The protective effect of obesity on mortality was diminished in individuals with higher muscle mass.
• The association between obesity and lower mortality was no longer significant after accounting for prior weight loss.

Conclusions:

• Higher fat mass, particularly in individuals with lower muscle mass, is linked to reduced mortality in CKD.
• Prior weight loss significantly confounds the apparent protective association of obesity with mortality in CKD.
• Inflammation did not appear to modify the relationship between obesity indicators and mortality in this cohort.